ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancers.

Allison M Barrett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.